1. Adelaide Research & Scholarship

Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 22 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Risks of Lynch Syndrome cancers for MSH6 mutation carriersSuthers, G.
2010Nilotinib versus Imatinib for newly diagnosed chronic myeloid leukemiaSaglio, G.; Kim, D.; Issaragrisil, S.; le Coutre, P.; Etienne, G.; Lobo, C.; Pasquini, R.; Clark, R.; Hochhaus, A.; Hughes, T.; Gallagher, N.; Hoenekopp, A.; Haque, A.; Dong, M.; Larson, R.; Kantarjian, H.
2010Characterization of the host immune response in human ganglia after Herpes ZosterGowrishankar, K.; Steain, M.; Cunningham, A.; Rodriguez, M.; Blumbergs, P.; Slobedman, B.; Abendroth, A.
2010Treatment of ocular surface squamous neoplasia with Mitomycin CGupta, A.; Muecke, J.
2010Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancerPeeters, M.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; Andre, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; Tzekova, V.; Collins, S.; Oliner, K.; Rong, A.; Gansert, J.
2010Global quantitative indices reflecting provider process-of-care: data-base derivationMoran, J.; Solomon, P.
2010Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX studyTebbutt, N.; Wilson, K.; Gebski, V.; Cummins, M.; Zannino, D.; van Hazel, G.; Robinson, B.; Broad, A.; Ganju, V.; Ackland, S.; Forgeson, G.; Cunningham, D.; Saunders, M.; Stockler, M.; Chua, Y.; Zalcberg, J.; Simes, R.; Price, T.
2010The cost-effectiveness of point of care testing in a general practice setting: Results from a randomised controlled trialLaurence, C.; Moss, J.; Briggs, N.; Beilby, J.
2010Seeking treatment for symptomatic malaria in Papua New GuineaDavy, C.; Sicuri, E.; Ome, M.; Lawrence-Wood, E.; Siba, P.; Warvi, G.; Mueller, I.; Conteh, L.
2010CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratificationSchroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.

Discover